- Market Realist•52 minutes ago
The overall share of revenues for Pfizer's Essential Health products fell marginally to 43.3% of the total revenues for 4Q16, from 45.6% in 4Q15.
- The Wall Street Journal•2 hours ago
OrbiMed Advisors has found success by funding startups that decode cancer’s secrets.
- Market Realist•2 hours ago
The key performers in Pfizer's (PFE) product portfolio include Lyrica, Ibrance, Xeljanz, and Eliquis, which are in the company's Innovative Health business.
PFE : Summary for Pfizer, Inc. Common Stock - Yahoo Finance
Pfizer Inc. (PFE)
NYSE - NYSE Real Time Price. Currency in USD
Add to watchlist
|Day's Range||34.16 - 34.46|
|52 Week Range||28.74 - 37.39|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||29.21|
|Dividend & Yield||1.28 (3.74%)|
|1y Target Est||N/A|